Workflow
法尔胜董事长谈主业表现不佳:全力争取改善经营业绩

Core Viewpoint - Jiangsu Farsen Co., Ltd. reported a significant decline in revenue and net profit for 2024, with a focus on improving operational performance through new product development and expansion into new business areas [2][3]. Financial Performance - In 2024, the company achieved an operating income of 312 million yuan, a decrease of 29.97% year-on-year - The net profit attributable to shareholders was -106 million yuan, marking a shift from profit to loss - Revenue from the metal products business and environmental business was 225 million yuan and 87.59 million yuan, respectively, representing declines of 10.74% and 54.90% year-on-year [2]. Business Development Strategies - The company aims to enhance its metal products segment by researching and developing high-margin new products - In the environmental sector, the company is exploring new avenues such as coal mine high-salinity water treatment - The subsidiary, Dalian Guantaiyuan Environmental Technology Co., Ltd., is expanding into construction waste classification and large-item waste treatment projects [3]. Operational Updates - The coal mine high-salinity water treatment project is expected to stabilize water output by May 2025, which will alleviate operational pressure on Guantaiyuan [3]. - The company is focusing on pricing strategies, raw material price fluctuation responses, and competitive advantages in its metal products business [4]. Competitive Positioning - The company is enhancing product value and lifespan by developing special high-strength steel wires - Long-term agreements with suppliers are being established to mitigate risks associated with raw material price fluctuations [4]. Industry Insights - Experts suggest that manufacturing companies can enhance market competitiveness through technological research and digital transformation - There is potential for Farsen to integrate its products into downstream processes and collaborate with industry chain enterprises to create comprehensive environmental treatment solutions [5].